fashion -WSS

fashion

author：knowledge 2025-09-29 05:45:11 - browse：73

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： BridgeBio heart drug succeeds in pivotal study

entertainment

WSS

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

FDA seeking to stop procedures at two unregulated stem cell clinics

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Amazon on where the company's health care bets are headed next

BridgeBio heart drug succeeds in pivotal study

focus

fashion

entertainment

What does generative AI mean for health care? We asked experts

Study: Hearing aids may slow cognitive decline in those at risk

After affirmative action ruling, medical educators look to 'holistic review'

Flagship, Pfizer team up in deal worth up to $7 billion

Wildfire smoke exposes gaps in outdoor worker protections

Illumina names Agilent executive as new CEO

Continuity nursing helped my family in our darkest PICU moments

How to fix cancer clinical trials' diversity problem

Moonlake's readout produced a cash windfall. Risks remain

Crinetics acromegaly drug succeeds in late

explore

Illumina names Agilent executive as new CEO

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Crinetics acromegaly drug succeeds in late

The (many) problems with a new study criticizing cancer screening

hotspot

leisure time

entertainment

focus